Loading clinical trials...
Loading clinical trials...
To determine the efficacy and tolerability of deferasirox in the treatment of Porphyria Cutanea Tarda. Primary objective - the elimination of all blistering within 6 months of treatment. Secondary o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Texas Southwestern Medical Center
Collaborators
NCT03118674 · Porphyria Cutanea Tarda, Hepatitis C
NCT01573754 · Porphyria Cutanea Tarda
NCT00213772 · Porphyria Cutanea Tarda
NCT00005103 · Porphyria Cutanea Tarda
UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials
Dallas, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions